MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Bradykinesia in Patients with Cervical Dystonia: Objective Assessment with Optical Sensor

    Z. Kosutzka, B. Gastanova, P. Matejicka, S. Kajan, P. Valkovic, M. Minar (Bratislava, Slovakia)

    Objective: To objectively quantify selected parameters of bradykinesia investigated by finger tapping in cervical dystonia patients using the Leap Motion Controller (LMC) sensor. Background: Bradykinesia,…
  • 2023 International Congress

    3D Multi-Delay pCASL to Understand Perfusion Changes in Patients with Parkinson’s disease with Mild Cognitive Impairment

    B. Thomas, Z. Mari, V. Mishra (Dallas, USA)

    Objective: To understand perfusion changes in patients with Parkinson’s disease (PD) with well-characterized mild cognitive impairment (MCI) using 3D multi-delay pseudo-continuous Arterial Spin Labeling (pCASL)…
  • 2023 International Congress

    Distinct characteristics of gut microbiome in patients with Parkinson’s disease according to the presence of premotor REM sleep behavior disorders

    S. Jo, JY. Lee, JW. Bae, SJ. Chung (Seoul, Republic of Korea)

    Objective: We aimed to investigate whether the composition and function of gut microbiome obtained from shotgun metagenomic sequencing are different between Parkinson’s disease (PD) patients…
  • 2023 International Congress

    Increased MD and decreased FA reflect cognitive impairment in PSP

    S. Kannenberg, AC. Hausmann, A. Schnitzler, CJ. Hartmann, C. Rubbert, J. Caspers (Düsseldorf, Germany)

    Objective: To identify white matter (WM) alterations associated with cognitive impairment in progressive supranuclear palsy (PSP). Background: PSP is accompanied with cognitive impairment [1;2], but…
  • 2023 International Congress

    A newly implemented NGS-based method to detect GBA1 variants in patients with Parkinson’s disease

    E. Monfrini, I. Palmieri, G. Cuconato, M. Percetti, P. Cortelli, A. Di Fonzo, EM. Valente (Milano, Italy)

    Objective: We aim to implement a new cost-effective and reliable next-generation-sequencing-based technology to test GBA1 gene in Parkinson disease (PD) patients. Background: Heterozygous variants in the…
  • 2023 International Congress

    Integrated analysis of phase 3 trials of foslevodopa/foscarbidopa demonstrated that majority of reported infusion site AEs including infections were non serious, mild to moderate in severity and did not result in treatment discontinuation.

    P. Odin, T. Kimber, B. Bergmans, E. Freire-Alvarez, F. Gandor, S. Isaacson, S. Dhanani, R. Hauser, M. O'Meara, A. Jeong, J. Jia, R. Gupta, L. Bergmann, M. Shah, L. Harmer, S. Talapala, J. Aldred (Lund, Sweden)

    Objective: To characterize reported infusion site infection adverse events (AEs) and their clinical management in patients with Parkinson’s disease (PD) treated with foslevodopa/foscarbidopa (LDP/CDP). Background:…
  • 2023 International Congress

    Tongue fasciculations and numbness: A case of calcifying pseudoneoplasm

    S. Hudaib, N. Stubbs, L. Simon, V. Blake, E. Nduom, C. Branson (Atlanta, USA)

    Objective: To describe a 61-year-old female who presents with abnormal tongue movement found to have right frontoparietal calcifying pseudoneoplasm of the neuraxis (CAPNON). Background: CAPNON…
  • 2023 International Congress

    Consideration of age and initial putaminal rim segment in distinguishing multiple system atrophy parkinsonian type

    W. Lee (Seoul, Republic of Korea)

    Objective: To improve diagnostic performance in distinguishing multiple system atrophy parkinsonian type (MSA-p), we investigated the iron deposition pattern in the putaminal lateral margin of…
  • 2023 International Congress

    Is a Parkinson’s Sialorrhoea service effective?

    C. Williams, J. Adenwalla, B. Mohamed, C. Marquis, C. Thomas, R. Lewis-Morton (cardiff, United Kingdom)

    Objective: Evaluate the efficacy and tolerance of Botulinum Toxin A (BoNT A) in managing sialorrhoea in People with Parkinsons (PwP)Assess impact on quality of life…
  • 2023 International Congress

    Diagnostic challenges in a case of SLC6A3-related Dopamine Transporter Deficiency Syndrome

    L. Jafri, J. Martindale (Winston Salem, USA)

    Objective: We report a case presenting with symptoms of classical Dopamine Transporter Deficiency Syndrome (DTDS) with negative results on initial whole-exome sequencing (WES), but eventually…
  • « Previous Page
  • 1
  • …
  • 308
  • 309
  • 310
  • 311
  • 312
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley